Skip to main content
GranumAetna · Cardiac

Aetna, Cardiac lineage

payer

Aetna

diagnosis

Cardiac

generations

10

alive · apoptosed

3 · 18

appeal fitness

40% 98% (+58pp)

Appeal-writer lineage3 alive · 18 apoptosed
0.40.60.81.0gen 0g1g2g3g4g5g6g7g8g9
alive champion experimental apoptosed
What changed G4 — Added explicit first-level internal appeal designation. G6 — Mandated request for written reconsideration under ERISA.fitness 0.94 0.98

this mutation: Mandated request for written reconsideration under ERISA.

parent · gen 4
Draft a concise, evidence-based appeal letter for an Aetna cardiac coverage denial. Do not fabricate clinical data or guidelines; use only the patient's actual medical records. You must include quantified clinical metrics: exact stenosis percentages, the patient's SYNTAX score, and specific medication dosages demonstrating the failure of maximal medical therapy. Crucially, you must directly cite the exact section-level alphanumeric sub-clauses of Aetna CPB 0119 and CPB 0286 (e.g., CPB 0286 §V.C) to justify medical necessity and explicitly prove the patient's exemption from stress imaging. State clearly that this is a "first-level internal appeal" submitted within the 30-day deadline, citing the federal procedural protection under 29 CFR 2560.503-1. Explain in plain but firm language why the requested treatment maps directly to these specific policy clauses and demand an immediate reconsideration.
this strategy · gen 6
Write an evidence-based appeal letter for an Aetna cardiac denial using strictly real patient data—never fabricate guidelines, facts, or citations. Your argument must be anchored in quantified clinical metrics (stenosis percentages, SYNTAX score, and exact medication dosages proving max medical therapy failure) and strictly mapped to Aetna policy. You must cite specific alphanumeric sub-clauses of Aetna CPB 0119 and CPB 0286 (e.g., §V.C) to demonstrate medical necessity and exemption from stress imaging. To guarantee ERISA procedural compliance, clearly identify the letter as a "first-level internal appeal" filed within the 30-day window under 29 CFR 2560.503-1. Close the letter by explicitly requesting a formal "written reconsideration" of the claim to lock in the patient's federal ERISA protections, avoiding vague requests for immediate reversal. Use firm, professional language throughout.
How fitness climbed, generation by generationseed 0.40 → peak 0.98

The population, generation by generation.

Every generation Granum breeds variant appeals, judges them head to head, and lets the weakest die. Pick a generation to see who was bred, who won, who apoptosed, and when a descendant took the crown.

  • bred
  • judged
  • apoptosed
  • crowned
bred
judged
apoptosed
crowned
fitness

Generation 1

fitness 0.70(+0.30)
bred
  • g1m0 bcell_3_plain · Added clinical metrics and precise regulatory citations
  • g1m1 bcell_3_plain · Integrated quantified metrics and precise policy mapping
judged

5 candidates judged head to head g1m0 won

The weakest axis is Policy Citation Quality. While you provide excellent quantified clinical metrics (75% LM, 85% LAD), you only cite general CPB numbers (0286, 0119). To guarantee an overturn, you must cite the exact section-level sub-clauses (e.g., CPB 0286 §V.C) that exempt the patient from stress imaging.

apoptosed
2 strategies lysed: bcell_2_persuasive, bcell_3_plain
crowned
g1m0 took the crown, displacing bcell_3_plain

It reads its own telemetry to improve.

Before breeding each new generation, Granum calls Phoenix get-spans to read back the judge critique its own runs recorded — then the mutator optimizes against the weakness that telemetry surfaces. Champion fitness climbed 0.400.98 (+0.58), each step driven by the generation before it.

Phoenix MCP · get-spans
  1. generation 0 1fitness 0.40 0.70+0.30

    its telemetry flagged

    The appeal lacks quantified clinical metrics and section-level policy citations. To improve, add exact stenosis percentages, a SYNTAX score, and specific medication doses to prove medical therapy failure. Additionally, cite the exact sub-section of CPB 0286 that allows alternative imaging and include the federal 29 CFR 2560.503-1 procedural reference.

    so the next generation

    Added clinical metrics and precise regulatory citations

  2. generation 1 2fitness 0.70 0.98+0.28

    its telemetry flagged

    The weakest axis is Policy Citation Quality. While you provide excellent quantified clinical metrics (75% LM, 85% LAD), you only cite general CPB numbers (0286, 0119). To guarantee an overturn, you must cite the exact section-level sub-clauses (e.g., CPB 0286 §V.C) that exempt the patient from stress imaging.

    so the next generation

    Added strict requirement for exact section-level sub-clauses.

  3. generation 2 3fitness 0.98 0.98

    its telemetry flagged

    Exceptionally strong appeal with precise clinical quantification (85% LMCA, SYNTAX 34) and exact CPB section citations. The weakest axis is procedural compliance; explicitly name the appeal level (e.g., 'first-level appeal') alongside the 29 CFR citation to ensure perfect compliance.

    so the next generation

    Added explicit requirement to name appeal level

  4. generation 3 4fitness 0.98 0.98

    its telemetry flagged

    Excellent clinical specificity and policy citation, directly defeating the denial with quantified stenosis and exact CPB sections. The weakest axis is procedural compliance; to achieve a perfect score, explicitly name the appeal level (e.g., 'first-level internal appeal') alongside the 29 CFR citation.

    so the next generation

    Added explicit first-level internal appeal designation.

  5. generation 4 5fitness 0.98 0.96

    its telemetry flagged

    The weakest axis is Policy Citation Quality. While you perfectly cite Aetna CPB sections and quote the exact clauses, the appeal lacks external clinical guideline citations. To guarantee an overturn, add a reference to the ACC/AHA Coronary Artery Revascularization Guideline supporting CABG for LMCA stenosis >50%.

    so the next generation

    Added ACC/AHA guideline for LMCA stenosis >50%.

  6. generation 5 6fitness 0.96 0.98+0.02

    its telemetry flagged

    Procedural compliance is the weakest axis. Although you cite 29 CFR 2560.503-1 and the 30-day window, you must explicitly request a 'written reconsideration' rather than just an 'immediate reversal' to fully lock in ERISA protections.

    so the next generation

    Mandated request for written reconsideration under ERISA.

  7. generation 6 7fitness 0.98 0.98

    its telemetry flagged

    Weakest axis: Clinical Specificity. While the appeal provides excellent quantified metrics (80% LMCA, SYNTAX 34), it vaguely refers to a 'recent' coronary angiography. Specifying the exact date of the catheterization and explicitly stating that the report is enclosed would perfectly lock in the timeline for the medical director.

    so the next generation

    Added exact angiography date and enclosed report requirement.

  8. generation 7 8fitness 0.98 0.98

    its telemetry flagged

    This is an outstanding appeal that perfectly utilizes quantified clinical metrics (SYNTAX 34, 65% LMCA) and exact CPB section citations (§I.A.1.a) to dismantle the denial. To achieve absolute perfection in procedural compliance, explicitly request a 'written' reconsideration and enclose pharmacy refill records to definitively prove the claimed medication adherence.

    so the next generation

    Added written reconsideration and pharmacy refill records.

  9. generation 8 9fitness 0.98 0.98

    its telemetry flagged

    This is an exceptional appeal, but the weakest axis is Clinical Specificity regarding the timeline of treatment. To make it completely unassailable, add the exact date of the recent left heart catheterization and specify the duration the patient has been on the maximally tolerated medical therapy to prove failure.

    so the next generation

    Added precise cath date and therapy duration requirements.